Inactive

Published extension of solicitation response deadline from 3/11/2025 to 3/14/2025 2:30PM CT for Human Insulin. Offerors are required to sign this document and return one copy. Please continue to monit... Published extension of solicitation response deadline from 3/11/2025 to 3/14/2025 2:30PM CT for Human Insulin. Offerors are required to sign this document and return one copy. Please continue to monitor SAM for future updates on this procurement.

Inactive

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0018 for an unrestricted procurement for Human Insulin, for the Department of Veterans... PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0018 for an unrestricted procurement for Human Insulin, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD) (for the Group 1 and 2 Requirements Only), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. All bottles/tubes must be individually boxed and must contain the bar code. All bottles/tubes must be compatible with automated dispensing units (Baxter ATC Canisters, Optifill, etc.). Solicitation # 36E79725R0018 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about March 4, 2025 with a tentative closing date of March 18, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Billy Fong. Questions can be e-mailed to Billy.Fong@va.gov.  The estimated annual requirements are as follows:  REQUIREMENT DESCRIPTION ITEM DESCRIPTION PACKAGE SIZE (PENS OR VIALS) TOTAL ESTIMATED ANNUAL USAGE (PENS OR VIALS) Group 1 1 HUMAN 70/30 PEN ( HUMAN 70/30, HUMULIN 70/30, NOVOLIN 70/30 AND BIOSIMILARS) 5x3ML 39,444 2 HUMAN 70/30 VIAL ( HUMAN 70/30, HUMULIN 70/30, NOVOLIN 70/30 AND BIOSIMILARS) 10ML 252,319 3 HUMAN N PEN (HUMAN N, HUMULIN N, NOVOLIN N AND BIOSIMILARS) 5x3ML 43,191 4 HUMAN N VIAL (HUMULIN N, NOVOLIN N AND BIOSIMILARS) 10ML 246,862 5 HUMAN R VIAL ( HUMIN R,HUMULIN R , NOVOLIN R AND BIOSIMILARS) 10ML 128,569 6 SHORT ACTING/INTERMEDIATE ANALOG MIX PEN (HUMAN MIX, HUMALOG 70/25, NOVOLOG 70/30 AND BIOSIMILARS) 5x3ML 532,944 7 SHORT ACTING/INTERMEDIATE ANALOG MIX VIAL (HUMAN MIX, HUMALOG 70/25, NOVOLOG 70/30 AND BIOSIMILARS) 10ML 205,539 Group 2 1 RAPID ACTING ANALOG PEN (ADMELOG,APIDRA,HUMALOG,NOVOLOG,LYUMJEV, FIASP, INSULIN ASPART,INSULIN LISPRO AND BIOSIMILARS) 5x3ML 1,372,854 2 RAPID ACTING ANALOG VIAL (ADMELOG,APIDRA,HUMALOG,NOVOLOG,LYUMJEV, FIASP,INSULIN ASPART,INSULIN LISPRO AND BIOSIMILARS) 10ML 1,253,288 Group 3 1 LONG ACTING PEN 100 UNITS/ML (LANTUS,INSULIN GLARGINE AND BIOSIMILARS) 5x3ML 1,875,294 2 LONG ACTING VIAL 100 UNITS/ML (LANTUS,INSULIN GLARGINE AND BIOSIMILARS) 10ML 1,723,433